Repeated Renal Interventions for Renal Cell Carcinoma in von Hippel-Lindau Disease: Long-Term Outcomes
European Urology Focus · 2026-10 · 12 (5) · 976-985
DOI: 10.1016/j.euf.2026.07.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Urology Focus, 2026-10. Verfasst von C A Jilg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany. Electronic address: cordula.jil…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Nephrectomy, von Hippel-Lindau Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome frequently associated with recurrent renal cell carcinoma (RCC), often requiring multiple renal interventions. Data on the timing and outcomes of repeated renal procedures remain limited. This study aimed to characterize patterns, timing, and outcomes of repeated renal interventions in VHL disease. Retrospective single-center analysis of 89 patients with VHL undergoing repeated renal interventions for RCC, including nephron-sparing surgery (NSS), nephrectomy, and minimally invasive interventions. Time to repeated interventions was assessed using kidney- and patient-based Kaplan-Meier analyses. Outcomes included perioperative parameters, metastasis, and overall survival. A total of 232 renal interventions were performed, with a median of two procedures per patient and a median follow-up of 14.6 yr. Among 204 surgical interventions (167 NSS, 37 nephrectomies), operative time, blood loss, and length of hospital stay were comparable. Kidney-based analyses (n = 178) showed median intervals of 10.7 and 8.2 yr between successive ipsilateral procedures, while nephrectomy occurred after a median of 24.6 yr. Patient-based analyses demonstrated median times of 4.9, 6.4, and 2.6 yr to the second, third, and fourth interventions. Metastases occurred in 10 patients, and median overall survival from first intervention was 20.9 yr. Perioperative complications were more frequent after NSS, whereas high-grade complications (Clavien-Dindo grade 4 or higher) were rare. Limitations include the single-center design and selected patient population. Repeated renal interventions are common in VHL disease. Organ-preserving strategies allow long-term renal preservation with acceptable oncologic outcomes and low rates of severe complications. Referral to experienced centers is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany. Electronic address: cordula.jilg@uniklinik-freiburg.de.
- Department of Urology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
- Department of Medicine IV - Nephrology and Primary Care, University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
- Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
- Department of Medicine IV - Nephrology and Primary Care, University of Freiburg, Faculty of Medicine. University of Freiburg, Germany; Department of Nephrology, Medical Center - University of Cologne, Faculty of Medicin…
Zitieren
APA
Jilg, C. A., Astheimer, S. C., Kotsis, F., Ganner, A., Schultze-Seemann, W., Neumann, H. P., Grabbert, M. T., Spohn, S., Kirste, S., Gratzke, C., Neumann-Haefelin, E., & Himmelsbach, R. (2026). Repeated Renal Interventions for Renal Cell Carcinoma in von Hippel-Lindau Disease: Long-Term Outcomes. European Urology Focus, 12(5), 976-985. https://doi.org/10.1016/j.euf.2026.07.002
Vancouver
Jilg CA, Astheimer SC, Kotsis F, Ganner A, Schultze-Seemann W, Neumann HP, et al. Repeated Renal Interventions for Renal Cell Carcinoma in von Hippel-Lindau Disease: Long-Term Outcomes. European Urology Focus. 2026;12(5):976-985. doi:10.1016/j.euf.2026.07.002
BibTeX
@article{Jilg2026,
author = {Jilg, C A and Astheimer, S C and Kotsis, F and Ganner, A and Schultze-Seemann, W and Neumann, H P and Grabbert, M T and Spohn, S and Kirste, S and Gratzke, C and Neumann-Haefelin, E and Himmelsbach, R},
title = {Repeated Renal Interventions for Renal Cell Carcinoma in von Hippel-Lindau Disease: Long-Term Outcomes},
journal = {European Urology Focus},
year = {2026},
volume = {12},
number = {5},
pages = {976--985},
doi = {10.1016/j.euf.2026.07.002}
}
EUVIMED